May 10, 2017 20:33 pm UTC| Business
WICHITA, Kan., May 10, 2017 -- NeoTherma Oncology, (NTO) a privately held medical device company developing novel non-invasive treatments for solid tumors, reported the results of a pre-clinical porcine study that...
U.S. Geothermal Inc. Reports First Quarter 2017 Results and Reaffirms 2017 Guidance
May 10, 2017 20:32 pm UTC| Business
Highlights Eighteenth consecutive quarter of positive cash flow from operations and EBITDAIncreased EBITDA and Net Income attributable to US Geothermal, from the year-ago periodIncreased output at Raft River...
May 10, 2017 20:31 pm UTC| Business
CHICAGO, May 10, 2017 -- SP Plus Corporation (NASDAQ:SP) (the “Company”) today announced that certain of its existing stockholders (the “Selling Stockholders”) intend to offer for sale 3,600,000 shares of its common...
Nature’s Sunshine Products Reports First Quarter 2017 Financial Results
May 10, 2017 20:31 pm UTC| Business
First quarter net sales of $83.1 million was up 0.8% year-over-year Net income of $2.2 million from continuing operations attributable to common shareholders, or $0.11 per diluted common share during the first quarterFirst...
Nature’s Sunshine Products Reports First Quarter 2017 Financial Results
May 10, 2017 20:31 pm UTC| Business
First quarter net sales of $83.1 million was up 0.8% year-over-year Net income of $2.2 million from continuing operations attributable to common shareholders, or $0.11 per diluted common share during the first quarterFirst...
Galena Biopharma Reports First Quarter 2017 Financial Results
May 10, 2017 20:31 pm UTC| Business
SAN RAMON, Calif., May 10, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results...
Galena Biopharma Reports First Quarter 2017 Financial Results
May 10, 2017 20:31 pm UTC| Business
SAN RAMON, Calif., May 10, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results...